Medicamen Organics IPO is a book built issue of Rs 10.54 crores. The issue is entirely a fresh issue of 31 lakh shares.
Medicamen Organics IPO opens for subscription on June 21, 2024 and closes on June 25, 2024. The allotment for the Medicamen Organics IPO is expected to be finalized on Wednesday, June 26, 2024. Medicamen Organics IPO will list on NSE SME with tentative listing date fixed as Friday, June 28, 2024.
Medicamen Organics IPO price band is set at ₹32 to ₹34 per share. The minimum lot size for an application is 4000 Shares. The minimum amount of investment required by retail investors is ₹136,000. The minimum lot size investment for HNI is 2 lots (8,000 shares) amounting to ₹272,000.
GYR Capital Advisors Private Limited is the book running lead manager of the Medicamen Organics IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Medicamen Organics IPO DRHP for detailed information.
Medicamen Organics IPO Details
| IPO Date | June 21, 2024 to June 25, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹32 to ₹34 per share |
| Lot Size | 4000 Shares |
| Total Issue Size | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Fresh Issue | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 8,600,000 |
| Share holding post issue | 11,700,000 |
| Market Maker portion | 172,000 shares |
Medicamen Organics IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
Medicamen Organics IPO Timeline (Tentative Schedule)
Medicamen Organics IPO opens on June 21, 2024, and closes on June 25, 2024.
| IPO Open Date | Friday, June 21, 2024 |
| IPO Close Date | Tuesday, June 25, 2024 |
| Basis of Allotment | Wednesday, June 26, 2024 |
| Initiation of Refunds | Thursday, June 27, 2024 |
| Credit of Shares to Demat | Thursday, June 27, 2024 |
| Listing Date | Friday, June 28, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 25, 2024 |
Medicamen Organics IPO Lot Size
Investors can bid for a minimum of 4000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹136,000 |
| Retail (Max) | 1 | 4000 | ₹136,000 |
| HNI (Min) | 2 | 8,000 | ₹272,000 |
| Lot Size Calculator | |||
Medicamen Organics IPO Promoter Holding
Mr. Bal Kishan Gupta is the promoter of the company.
| Share Holding Pre Issue | 81.21% |
| Share Holding Post Issue |
About Medicamen Organics Limited
Medicamen Organics Limited was incorporated in 1995 and develops, manufactures, and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer.
The company’s product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company’s products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 Sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.
As of September 30, 2023, the company employed a total of 116 people.
Medicamen Organics Limited Financial Information (Restated)
Medicamen Organics Limited’s revenue increased by 8.38% and profit after tax (PAT) rose by 937.7% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 3,450.88 | 3,211.98 | 2,707.21 | 2,634.37 |
| Revenue | 1,132.60 | 2,296.24 | 2,118.67 | 2,505.96 |
| Profit After Tax | 129.11 | 95.78 | 9.23 | 29.81 |
| Net Worth | 1,180.83 | 851.71 | 755.92 | 746.72 |
| Reserves and Surplus | 380.83 | 251.71 | 155.92 | 146.72 |
| Total Borrowing | 1,062.50 | 1,179.50 | 1,024.57 | 958.97 |
| Amount in ₹ Lakhs | ||||
Key Performance Indicator
The market capitalization of Medicamen Organics IPO is Rs 39.78 Cr.
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.11 | 2.21 |
| P/E (x) | 30.53 | 15.41 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2023 that is available in RHP.
Objects of the Issue (Medicamen Organics IPO Objectives)
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Funding of expenses proposed to be incurred towards Product registration in the international markets;
- Plant updation and increase in production capacity;
- Funding working capital requirements of our Company; and
- General Corporate Purposes.
Medicamen Organics IPO Prospectus
Medicamen Organics Limited Contact Details
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: cs@mediorganics.in
Website: http://www.medicamenorganics.com/
Medicamen Organics IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: medicamen.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/